期刊文献+

特发性肺(间质)纤维化治疗进展 被引量:1

暂未订购
导出
摘要 特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)是一种原因不明的慢性炎症性间质性肺疾病.以弥漫性肺泡炎和肺泡结构紊乱并最终导致弥漫性肺间质纤维化为特征。可侵犯肺泡壁、肺泡腔。形成限制性通气功能障碍和动脉血气异常.常表现为低氧血症、呼吸性碱中毒.最后可导致呼吸衰竭而死亡。IPF发病率约为5/10万.近年来有增高趋势,且传统的治疗至今不能令人满意.经治疗5年生存率低于50%。10年生存率仅为30%.因此对IPF治疗进展进行综述有重要的临床意义。
出处 《中国初级卫生保健》 2008年第4期88-89,共2页 Chinese Primary Health Care
  • 相关文献

参考文献8

二级参考文献43

  • 1钱皓瑜,马希涛.特发性肺纤维化患者的Th1/Th2细胞因子失衡[J].中国误诊学杂志,2004,4(7):1068-1069. 被引量:5
  • 2李桂莲,何冰,赵桂荣,高文莉,李文慧,李广欣,汤秀英.激素对油酸及大肠杆菌所致大鼠急性肺损伤疗效观察[J].北京医科大学学报,1995,27(1):40-42. 被引量:8
  • 3张德平,庄谊,孟凡清,殷凯生.γ干扰素对实验性肺纤维化大鼠肺泡炎和肺纤维化的影响[J].中国呼吸与危重监护杂志,2006,5(3):189-192. 被引量:11
  • 4Li HP,Li X,He GJ,et al.The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats.Respirology,2004,9:25-32.
  • 5Szapiel SV,Elson NA,Fulmur JD,et al.Bleomycin-induced interstitial pulmonary disease in the nude,athymic mouse.Am Rev Respir Dis,1979,120:893-899.
  • 6Kivirikko KI,Laitinen O,Prockop DJ.Modifications of a specific assay for hydroxyproline in urine.Anal Biochem,1967,19:249-255.
  • 7Segel MJ,Izbicki G,Cohen PY,et al.Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis.Am J Physiol Lung Cell Mol Physiol,2003,285:L1255-1262.
  • 8Chen ES,Greenlee BM,Wills-Karp M,et al.Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.Am J Respir Cell Mol Biol,2001,24:545-555.
  • 9Prior C,Haslam PL.In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.Clin Exp Immunol,1992,88:280-287.
  • 10Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med,1998, 157 : 1301-1315.

共引文献668

同被引文献13

  • 1徐兴祥,朱元珏.特发性肺纤维化治疗的研究进展[J].国外医学(呼吸系统分册),2004,24(3):146-149. 被引量:5
  • 2侯杰.特发性肺纤维化[J].中国厂矿医学,2005,18(3):193-194. 被引量:6
  • 3Nicholson AG,Fulford LG,Colby TV,et al.The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med,2002,166:173-177.
  • 4Kuwano K,Nakashima N,Inoshima I,et al.Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias.Eur Respir J,2003,21:232 240.
  • 5Selman M,Thannickal VJ,Pardo A,et al.Idiopathic pulmonary fibrosis:pathogenesis and therapeutic approaches.Drugs,2004,64:405-430.
  • 6Raghu G,Depaso WJ,Cain K,et al.Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis:a prospective double-blind,randomized,placebocontrolled clinical trial.Am Rev Respir Dis,1991,144:291-296.
  • 7Flaherty KR,Toews GB,Lynch JP 3rd,et al.Steroids in idiopathic pulmonary fibrosis:a prospective assessment of adverse reactions,response to therapy,and survival.Am J Med,2001,110:278-282.
  • 8Tengstrand B,Ernestam S,Engvall IL,et al.TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis.Six case reports.Lakartidningen,2005,102:3788-3790,3793.
  • 9张华根,梁标.特发性肺纤维化发病机制研究新进展[J].四川医学,2009,30(1):141-144. 被引量:5
  • 10艾进颖,王红阳,刘信荣,付爱双.低分子肝素治疗博来霉素诱导大鼠肺纤维化的研究[J].中华结核和呼吸杂志,2009,32(5):384-385. 被引量:4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部